$555 Million is the total value of SECTOR GAMMA AS's 30 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 35.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABT | Buy | ABBOTT LABS | $66,250,000 | +7.5% | 1,105,642 | +2.4% | 11.94% | +15.3% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $47,575,000 | +12.8% | 1,741,380 | +2.4% | 8.57% | +21.0% |
BAX | Buy | BAXTER INTL INC | $46,532,000 | +3.7% | 715,438 | +3.0% | 8.39% | +11.1% |
MRK | Buy | MERCK & CO INC | $39,502,000 | +25.7% | 725,200 | +29.8% | 7.12% | +34.8% |
SHPG | Buy | SHIRE PLCsponsored adr | $24,646,000 | +136.9% | 164,975 | +146.0% | 4.44% | +154.0% |
LLY | Buy | LILLY ELI & CO | $19,537,000 | +50.8% | 252,514 | +64.6% | 3.52% | +61.7% |
NUVA | Buy | NUVASIVE INC | $19,422,000 | +27.6% | 371,997 | +43.0% | 3.50% | +36.8% |
CAH | New | CARDINAL HEALTH INC | $14,182,000 | – | 226,263 | +100.0% | 2.56% | – |
LH | Buy | LABORATORY CORP AMER HLDGS | $13,652,000 | +7.0% | 84,400 | +5.5% | 2.46% | +14.7% |
THC | Buy | TENET HEALTHCARE CORP | $12,950,000 | +83.5% | 534,021 | +14.7% | 2.33% | +96.6% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $12,056,000 | +285.9% | 273,500 | +340.4% | 2.17% | +313.9% |
AGN | Buy | ALLERGAN PLC | $10,821,000 | +5.7% | 64,300 | +2.7% | 1.95% | +13.3% |
UHS | New | UNIVERSAL HLTH SVCS INCcl b | $10,298,000 | – | 86,973 | +100.0% | 1.86% | – |
LXRX | Buy | LEXICON PHARMACEUTICALS INC | $7,324,000 | -11.4% | 854,592 | +2.1% | 1.32% | -5.0% |
PDCO | Buy | PATTERSON COMPANIES INC | $6,941,000 | -36.6% | 312,232 | +3.0% | 1.25% | -32.0% |
PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $4,403,000 | +80.9% | 134,800 | +169.6% | 0.79% | +94.1% |
SRPT | New | SAREPTA THERAPEUTICS INC | $3,779,000 | – | 51,006 | +100.0% | 0.68% | – |
AGIO | New | AGIOS PHARMACEUTICALS INC | $3,353,000 | – | 41,000 | +100.0% | 0.60% | – |
SGMO | New | SANGAMO THERAPEUTICS INC | $1,824,000 | – | 96,000 | +100.0% | 0.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-09
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-08 |
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.